You have no items in your shopping cart.
- Human IFNL1 protein (Active) [orb359215]Featured
Active> 97% as determined by SDS-PAGE and HPLC.
19.8 kDa
E.Coli
5 μg, 100 μg, 500 μg - Featured

Greater than 85% as determined by SDS-PAGE.
27.7 kDa
E.coli
100 μg, 1 mg, 20 μg - Featured

Greater than 85% as determined by SDS-PAGE.
36.6 kDa
E.coli
20 μg, 100 μg, 1 mg - Human IL-28A (C-6His) Protein [orb1471715]Featured

Greater than 95% as determined by reducing SDS-PAGE.
20.6 KDa
Mammalian
10 μg, 50 μg - Human IL-28B Protein [orb1471716]Featured

Greater than 95% as determined by reducing SDS-PAGE.
19.6 KDa
Mammalian
10 μg, 50 μg - Human IL-29 (C-10His) Protein [orb1471744]Featured

The purity of the protein is greater than 95% as determined by SDS-PAGE and Coomassie blue staining.
21.4 KDa
Mammalian
50 μg, 10 μg - Recombinant human IL-29 protein (Active, HEK293) [orb1817195]Featured

>95% as determined by SDS-PAGE
29-35 kDa
50 μg, 10 μg, 500 μg - Human IL-28A [orb3002271]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20.6 KDa. Observed: 20 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human IL-29 [orb3002298]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 21.4 KDa. Observed: 25-36 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human IL-28B [orb3002315]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20.67 KDa. Observed: 22 KDa, reducing conditions
10 μg, 50 μg, 1 mg, 500 μg







